NRx Pharmaceuticals, Inc. (NRXP)
NASDAQ: NRXP · Real-Time Price · USD
2.940
+0.100 (3.52%)
At close: Apr 24, 2026, 4:00 PM EDT
2.970
+0.030 (1.02%)
After-hours: Apr 24, 2026, 7:57 PM EDT
NRx Pharmaceuticals Market Cap
NRx Pharmaceuticals has a market cap or net worth of $97.12 million as of April 24, 2026. Its market cap has increased by 222.66% in one year.
Market Cap
97.12M
Enterprise Value
89.96M
1-Year Change
222.66%
Ranking
Category
Stock Price
$2.94
Market Cap Chart
Since November 20, 2017, NRx Pharmaceuticals's market cap has increased from $65.80M to $97.12M, an increase of 47.60%. That is a compound annual growth rate of 4.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 97.20M | 27.73% |
| Dec 31, 2025 | 76.10M | 186.09% |
| Dec 31, 2024 | 26.60M | -31.09% |
| Dec 29, 2023 | 38.60M | -48.60% |
| Dec 30, 2022 | 75.10M | -73.28% |
| Dec 31, 2021 | 281.10M | 328.51% |
| Dec 31, 2020 | 65.60M | 2.02% |
| Dec 31, 2019 | 64.30M | -30.26% |
| Dec 31, 2018 | 92.20M | 44.97% |
| Dec 29, 2017 | 63.60M | -3.34% |
| Nov 20, 2017 | 65.80M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Anixa Biosciences | 105.28M |
| Coya Therapeutics | 103.45M |
| Aldeyra Therapeutics | 102.31M |
| Turn Therapeutics | 101.58M |
| ProMIS Neurosciences | 99.63M |
| Q32 Bio | 97.29M |
| Rani Therapeutics Holdings | 94.82M |
| Coeptis Therapeutics Holdings | 93.97M |